Status:
COMPLETED
A Single Group Study to Evaluate the Effects of a Myo-Inositol and D-Chiro Inositol Supplement on Symptoms Associated With Polycystic Ovary Syndrome and Hormone Imbalance
Lead Sponsor:
Optify
Collaborating Sponsors:
Citruslabs
Conditions:
Polycystic Ovary Syndrome
Hormone Imbalance
Eligibility:
FEMALE
18-55 years
Phase:
NA
Brief Summary
This is a virtual single group study that will last 12 weeks. 40 female participants will take 4 capsules of the Optify Myo Inositol and D-Chiro Inositol Plus Folate and Vitamin D supplement per day. ...
Eligibility Criteria
Inclusion
- Women aged between 18 - 55
- BMI less than 35
- Self-reported symptoms of PCOS like irregular periods, excessive hair growth, weight gain, oily skin, or acne
- Self-reported concerns around irregular menstrual cycles and ovulation, mood swings, stress, irritability, and low energy
- Self-reported concerns with hormonal skin issues
- Has access to a tape measure for waist measurement
- Generally healthy - don't live with any uncontrolled chronic disease
Exclusion
- Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders
- Anyone with known severe allergic reactions
- Anyone who is pregnant or breastfeeding
- Unwilling to follow the study protocol
Key Trial Info
Start Date :
September 8 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 6 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06158932
Start Date
September 8 2023
End Date
January 6 2024
Last Update
April 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Citruslabs
Santa Monica, California, United States, 90404